本页面由Tiger Trade Technology Pte. Ltd.提供服务

Zentalis Pharmaceuticals, LLC

2.40
-0.1200-4.76%
盘后:2.400.00000.00%16:10 EDT
成交量:57.01万
成交额:138.88万
市值:2.27亿
市盈率:-1.23
高:2.54
开:2.53
低:2.39
收:2.52
52周最高:6.95
52周最低:1.21
股本:9,467.19万
流通股本:7,482.79万
量比:0.70
换手率:0.76%
股息:- -
股息率:- -
每股收益(TTM):-1.9591
每股收益(LYR):-1.9100
净资产收益率:-66.75%
总资产收益率:-33.15%
市净率:1.58
市盈率(LYR):-1.26

数据加载中...

2024/02/29

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/02/27

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/27

重要事件披露

Form 8-K - Current report
2024/02/15

重要事件披露

Form 8-K - Current report
2024/02/15

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/13

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/13

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/09

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/09

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/01/25

重要事件披露

Form 8-K - Current report
2024/01/08

重要事件披露

Form 8-K - Current report